Unknown

Dataset Information

0

Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-? activated adipose derived mesenchymal stem cells in breast cancer model.


ABSTRACT: Gene modified or cytokine activated mesenchymal stem cells (MSCs) have been used as a treatment in various types of cancer. Moreover, irradiation is usually applied as either a standard primary or adjuvant therapy. Here, we showed that the expression of TNF related apoptosis-inducing ligand (TRAIL) and Dickouf-3 (Dkk-3), the promising anticancer proteins, increased in murine adipose-derived mesenchymal stromal cells (AD-MSCs) following activation with TNF-?, resulting in the induction of apoptosis in cancer cells. Also, anticancer effects of TNF-? activated AD-MSCs were intensified with irradiation. In vivo results showed that TNF-? preactivated AD-MSCs combined with irradiation decreased tumor size and increased survival rate in tumor bearing mice. On the other hands, both TNF-? preactivated AD-MSCs with or without irradiation prevented metastasis in ling and liver, and increased apoptosis in tumor mass. Finally, flowcytometry assay demonstrated that naïve AD-MSCs combined with irradiation but not TNF-? activated MSCs with irradiation increased Treg population in lymph node and spleen. Altogether, obtained results suggest that TNF-? activated MSCs combined with irradiation therapy can serve as new strategy in breast cancer therapy.

SUBMITTER: Mohammadpour H 

PROVIDER: S-EPMC4916474 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model.

Mohammadpour Hemn H   Pourfathollah Ali Akbar AA   Nikougoftar Zarif Mahin M   Shahbazfar Amir Ali AA  

Scientific reports 20160622


Gene modified or cytokine activated mesenchymal stem cells (MSCs) have been used as a treatment in various types of cancer. Moreover, irradiation is usually applied as either a standard primary or adjuvant therapy. Here, we showed that the expression of TNF related apoptosis-inducing ligand (TRAIL) and Dickouf-3 (Dkk-3), the promising anticancer proteins, increased in murine adipose-derived mesenchymal stromal cells (AD-MSCs) following activation with TNF-α, resulting in the induction of apoptos  ...[more]

Similar Datasets

| S-EPMC4585933 | biostudies-other
| S-EPMC9587124 | biostudies-literature
| S-EPMC4628915 | biostudies-literature
| S-EPMC4884788 | biostudies-literature
| S-EPMC7226671 | biostudies-literature
| S-EPMC4549224 | biostudies-literature
| S-EPMC8110535 | biostudies-literature
| S-EPMC7040357 | biostudies-literature
| S-EPMC10651838 | biostudies-literature
| S-EPMC3739795 | biostudies-literature